Volume 4
Journal of Infectious Diseases and Treatment
ISSN: 2472-1093
Page 33
Euro Infectious Diseases 2018 &
Histopathology 2018
September 27-29, 2018
&
JOINT EVENT
September 27-29, 2018 Rome, Italy
5
th
International Conference on
Histopathology & Cytopathology
10
th
Euro-Global Conference on
Infectious Diseases
Histopathologic evaluation and prevalence of gastric cancer in Herat provnice of Afghanistan for the
first time
Haroon Firooz
Herat University, Afghanistan
Background:
Gastric cancer is one of the leading causes of cancer related death worldwide. Many patients have inoperable
diseases at diagnosis or have recurrent diseases after resection with curative intent. Gastric cancer is seperated anatomically
into true gastric adenocarcinoms and gastro-oesophageal junction adenocarcinomas, and histologically into diffuse and
intestinal types. Gastric cancer should be treated by teams of experts from different diciplines. Surgery is the only curative
treatment for locally advanced diseases. Chemotherapy is usually implemented in combination with surgery. In metastatic
diseases, outcomes are poor with median survival being around one year. For the first time in Herat province of Afghanistan
author decided to have a researh on gastric cancers. Since there was no pathology laboraroy in the past, no data is avaible about
previlance and incidince of this diseases. Author has collected the data and related possible causes of gastric cancer in my
cancer diagnostic center, in order to inform the community about this dangerous diseases. Unfortunately in our country most
of patients diagnose in late stages of cancer because of lack of facilities and awaraness of diagnostic methods.
Objective:
To evaluate the histopathologic types of gastric cancer and related risk factors in Herat city.
Methods:
This research is a descriptive study (based on existing data) or cross sectional study. The study population is consist
of 152 gastric biopsies from the patients who were suffering form gastric disorders. Endoscopiaclly mucosal resection (biopsy)
is taken by endoscopists and referred to Firooz pathology laboratory for diagnosis. The research data is from 01/01/2015 to
01/01/ 2017.
Materials:
All tissues were excised by endoscopy as mucosal resections (biopsies). The diagnosis of the tissue samples were
according histologic prepared and staind slides ( H&E) after standerd histotechnology.
Results:
In this study, 152 biopsies were assessed. 137 patients diagnosed gastric cancer, among them 95(69.2%) were males
and 42(30.7%) females. 45.26% of cancer patients aged over 60 years old. In 71.05% of biopsies revealed intestinal type
adenocarcinoma, 11.8% of patients the biopsies showed diffuse type carcinoma. Dysplasia were noted in 6.57% of biopsies.
Finally 2.70% of biopsies revealed atrophic gastritis and 0.65% of cases revealed lymphoma NHL. In 49.6 % of cases the tumors
had proximal location and in 50.44% of cases the tumor had distal location. Low grade adenocarcinoma were seen in 22.6% of
cases, moderately differentiated were seen in 19.7% of cases and poorly differentiated were seen in 57.7% of cases. In this study
41.6% of cases revealed
Helicobacter pylori
in gastric mucosa. Patients who diagnosed gastric cancer did not use alcohol and
tabacco, most used meat in their daily diet.
Conclusion:
By considering this fact that gastric cancer is a dangesrous diseases specially in undeveloped countries like
Afghanistan and kills many people, it is mandatory for physician to diagnose gastric cancer in onset and early stages, in order
to survive patients. Acording to our study most of referring patients (57.7%) suffered from Grade III adenocarcinoma and
diagnosed poorly differentiated adenocarcinoma during there first endoscopy and histopathologic examination and the mean
age for gastric cancer was 57.8, therfore it is recommended for doctors to consider abdominal discomfort and gastric disorders
as a serious problem and do necessary investigative methods especially in ages above 45 years with special emphasis on early
diagnosis of disease inorder to redue and decrease death rates.
Biography
Haroon Firooz has completed his speciality program in field of Pathology in Goethe University Frankfurt, Germany. He is the Head of the Pathology Department in
Herat Medical Faculty of Afghanistaan. He has published more than eight papers in Herat University Medical Journal.
haroonfirooz@gmail.comHaroon Firooz, J Infec Dis Treat 2018, Volume 4
DOI: 10.21767/2472-1093-C1-002




